Expressions and functional roles of novel IL-2 binding molecules (p70, 75) in the differentiation of B cells into Ig secreting cells were explored by using human several B cell lines and tonsillar B cells. Affinity-crosslinking studies revealed that five of nine B cell lines expressed p70 and p75 without detectable Tac antigen (p55) expression and the expression was associated with B cell maturation. In tonsillar B cells, small high-density B cells did not express p70 and p75, whereas large low-density B cells, which were thought to be activated in vivo, expressed them. Binding assays of radiolabeled IL-2 showed that the affinity of these molecules was intermediate (kD = 1-3 nM, 700-3,000 sites/cell). Furthermore, high concentrations of IL-2 (> 100 U/ml) induced Ig productions in large B cells and two of five cell lines. These results taken together suggest that B cells may express novel IL-2 binding molecules, associated with B cell differentiation and differentiate into Ig secreting cells by IL-2 through novel IL-2 binding molecules.
Introduction
IL-2 is a T cell-derived lymphokine with growth and differentiation promoting activities on responding cell populations through its interaction with high affinity IL-2 receptor (IL-2R)' (1) (2) (3) . Recently, the existence of novel IL-2 binding molecules (p70, 75) differed from Tac antigen (p55) has been demonstrated in T-cells, NK cells and a B cell line and high affinity IL-2R is thought to be made up of p70, 75, and p55 (4) (5) (6) (7) (8) . Furthermore, it is suggested that p70, 75 are responsible for signal transduction of IL-2 (9-13).
In artificially activated B cells and some B cell lines, it is generally accepted that IL-2 induces proliferation or Ig secretion through high affinity IL-2 receptor (14) (15) (16) (17) , whereas evidences that IL-2, in some circumstance, may provide signals in B cells lacking Tac antigen are also accumulating (18, 19) . However, the precise characterization of this mechanism remains unknown. 1 . Abbreviations used in this paper: DSS, disuccinimidyl suberate; IL-2R, IL-2 receptor; PK-C, protein kinase C; PMA, phorbol myristate acetate; rBSF2, recombinant B cell stimulating factor 2; SAC, Staphylococcus aureus Cowan 1.
Here, we show the existence of p70, 75 in human several B cell lines and large low-density B cells, which are thought to be activated in vivo, and the differentiation of B cells by IL-2 and discuss the mechanism of B cell differentiation by IL-2.
Methods
Cell line. Human B cell lines, NALM6, Daudi, Raji, Ramos, SKW64, CESS, ARH-77, U266, and RPMI 8866 cells have been maintained in RPMI 1640 (Gibco, Grand Island, NY) containing 10% FCS (Sterile Systems, Logan, UT), 2 mM L-glutamine, 100 ug streptomycin and 100 U penicillin/ml ( Radiolabeled IL-2 binding assay. rIL-2 was iodinated with Na'25I by the chloramine T method and the specific activity of "25I-labeled IL-2 ('25I-IL-2) was 1.5-2.4 X 104 cpm/ng. IL-2 binding assay was performed as reported previously (21) . Briefly, cells (2 X 106) were incubated with serial dilutions of '25I-IL-2 in a total volume of 150 Ml RPMI 1640 containing 0.02% NaN3, 1% BSA and 25 mM Hepes for 1 h at 40C. The mixtures were then centrifuged, the supernatants were removed, and the precipitated cells were resuspended in 100 ,l of PBS.
The cell suspensions were layered on 750 ;d of RPMI 1640 containing 1 M sucrose, 0.02% BSA, and 0.02% NaN3 and were centrifuged at 12,000 rpm for 3 min at 4°C. The radioactivities of the resulting supernatants and cell precipitates were then counted. The specific binding of '25I-IL-2 to cells was calculated by subtracting the count of the sample containing excess unlabeled IL-2 (100-fold) for competitive binding from observed count.
Gel-electrophoresis ofIL-2 binding molecules. '251I-IL-2 was crosslinked to IL-2 binding molecules as previously described (4) (Table I) .
We examined the molecular weights of IL-2 binding molecules by the affinity crosslinking method as described in Methods. Fig. 1 (Table I and Fig. 1, lanes 11 and JO) . SAC-stimulated B-cells had low (Kd = 16 nM, sites/cell = 14,300) and high affinity IL-2R (4 = 24.5 pM, sites/cell = 1,320), and expressed not only p70, 75 but also Tac antigen (p55) in addition to a broad band of 160-200 kD (Table I , Fig.   1, lane 12) , although a precise characterization of this broad band remains unknown (4, 7, 8) .
However, two of seven experiments indicated that IL-2 at a dose induced IgM productions in large B cells but maximal induction was obtained at a high dose (Fig. 4 ). In the presence of H-3 1, which completely blocked the binding of IL-2 to Tac antigen (13), the induction by low doses of IL-2 was inhibited and high concentrations of IL-2 were required for B cell differentiation (Fig. 4) ] % .al 4 h and affinity crosslinkages were carried out. Fig. 5 shows that IL-2 also induced Tac antigen expression in these populations, indicating that large B cells might express Tac antigen that could associate with p70, 75 to form high affinity IL-2R. However, Northern blot analysis and affinity crosslinking study revealed that SKW6-4 cells were not induced to express Tac antigen by IL-2 (data not shown).
Large B cells proliferate in response to IL-2. Finally, we examined the proliferative response to IL-2 in B cells. A representative result of three experiments showed in Table II . Increase of [3Hlthymidine incorporation was observed in large B cells by high doses of IL-2 but not in small B cells. The response was dose-dependent and high concentrations of IL-2 were also required for proliferation, which was compatible with differentiation. These results taken together suggest that large low-density B cells, which are thought to be activated in vivo, express novel IL-2 binding molecules and may proliferate and differentiate through the interaction ofIL-2 with them.
Discussion
Several previous studies showed that in vitro artificially activated B cells expressed high-affinity IL-2R and physiological concentrations of IL-2 induced proliferation and differentiation through its interaction with high affinity IL-2R (14-17). It was also reported that high concentrations of IL-2 were required for differentiation of B cells without Tac antigen expression (18, 19) . -u functionally and phenotypically, but we can not exclude the possibility that B cell differentiation by IL-2 was due to indirect effects of contaminating T cells or lymphokines derived from T cells. Therefore, we examined whether monoclonal B cell lines expressed IL-2 binding molecules. IL-2 binding and affinity crosslinking study revealed that some B cell lines expressed p70 and p75 and IL-2 functioned through its interaction with these molecules and suggest that the expression of p70, p75 was correlated with B cell maturation. With regard to responsive to IL-2, we can classify them into two groups. One group includes cell lines that are reactive to IL-2 (SKW6-4 and ARH-77) and the other includes cell lines that are unresponsive to IL-2 (U266, RPMI 8866, and CESS) irrespective of the existence of p70 and p75. We can consider some possibilities for the explanation in this phenomenon. First, simply cell stages may account for the difference. Secondly, it may be due to p70, 75 molecules by themselves, but precise characterization of them such as amino acid analysis remains unknown at present. Thirdly, postreceptor defects may exist in U266, RPMI 8866, and CESS. We examined whether IL-2 bound to p70, 75 was rapidly internalized or not. In unresponsive cell lines, the internalization of IL-2 occurred and the kinetic pattern ofthe internalization was similar to that in responsive cell lines. It is reported that IL-2 produces a rapid and transient redistribution of protein kinase C (PK-C) from the cytosol to the plasma membrane in T cells and the activation of PK-C seems to have a crucial role in signal transduction of IL-2 (25) . In preliminary experiments, phorbol myristate acetate (PMA) (0.1-10 ng/ml), an activator ofPK-C transposition, induced Ig productions in both SKW6-4 and CESS cells. Moreover, synergistic or additive effects between IL-2 and PMA were not recognized at the maximal response by each stimulus but additive effects between them at suboptimal doses were observed in SKW6-4 cells, suggesting that activation of PK-C may play an important role in B cell differentiation by IL-2 and the third hypothesis seems likely. Further studies are necessary to evaluate the difference.
Freshly isolated unstimulated peripheral blood T cells and NK cells are reported to express p70, 75 but not Tac antigen and to respond to high concentrations of IL-2 (8, 11, 12, 26) . In our crosslinking and IL-2 binding studies, T cells stimulated by PHA displayed more p70, 75 than nonstimulated T cells suggesting that these molecules are also induced in activated T cells.
These results taken together have demonstrated that IL-2 directly induces Ig secretion in B cells through p70, 75 and p70, 75 may be expressed in association with B cell differentiation. We hope that these findings should be helpful in the analysis of abnormalities in B cells of immunodeficient patients and be applicable to the therapy by IL-2. In fact, Weyand et al. reported that administration in vivo of high doses of IL-2 to mice induced a polyclonal IgM response (but not IgG), probably through their direct effects on B cells and that mice pretreated with IL-2 were protected from septic death, caused with E. coli (27, 28) .
